MITTEL SPA (MIT.MI) Fundamental Analysis & Valuation

BIT:MIT • IT0001447348

1.745 EUR
0 (0%)
Last: Mar 5, 2025, 10:29 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This MIT.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to MIT. MIT was compared to 58 industry peers in the Financial Services industry. MIT has an excellent profitability rating, but there are some minor concerns on its financial health. MIT has a valuation in line with the averages, but on the other hand it scores bad on growth. Finally MIT also has an excellent dividend rating. These ratings could make MIT a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

9

1. MIT.MI Profitability Analysis

1.1 Basic Checks

  • In the past year MIT was profitable.
  • MIT had a positive operating cash flow in the past year.
  • MIT had positive earnings in each of the past 5 years.
  • Each year in the past 5 years MIT had a positive operating cash flow.
MIT.MI Yearly Net Income VS EBIT VS OCF VS FCFMIT.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

1.2 Ratios

  • The Return On Assets of MIT (12.51%) is better than 88.00% of its industry peers.
  • With a decent Return On Equity value of 19.94%, MIT is doing good in the industry, outperforming 72.00% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 19.42%, MIT belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
  • MIT had an Average Return On Invested Capital over the past 3 years of 14.88%. This is above the industry average of 10.33%.
  • The last Return On Invested Capital (19.42%) for MIT is above the 3 year average (14.88%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.51%
ROE 19.94%
ROIC 19.42%
ROA(3y)4.19%
ROA(5y)2.58%
ROE(3y)6.68%
ROE(5y)4.21%
ROIC(3y)14.88%
ROIC(5y)11.03%
MIT.MI Yearly ROA, ROE, ROICMIT.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15

1.3 Margins

  • MIT has a Profit Margin of 33.36%. This is in the better half of the industry: MIT outperforms 72.00% of its industry peers.
  • In the last couple of years the Profit Margin of MIT has grown nicely.
  • MIT has a Operating Margin of 49.36%. This is amongst the best in the industry. MIT outperforms 86.00% of its industry peers.
  • In the last couple of years the Operating Margin of MIT has grown nicely.
  • MIT has a better Gross Margin (100.33%) than 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of MIT has grown nicely.
Industry RankSector Rank
OM 49.36%
PM (TTM) 33.36%
GM 100.34%
OM growth 3Y8.63%
OM growth 5Y58.53%
PM growth 3Y215%
PM growth 5Y95.71%
GM growth 3Y0.76%
GM growth 5Y10.13%
MIT.MI Yearly Profit, Operating, Gross MarginsMIT.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MIT.MI Health Analysis

2.1 Basic Checks

  • MIT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, MIT has about the same amount of shares outstanding.
  • MIT has a better debt/assets ratio than last year.
MIT.MI Yearly Shares OutstandingMIT.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
MIT.MI Yearly Total Debt VS Total AssetsMIT.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 2.36 indicates that MIT is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • MIT has a Altman-Z score (2.36) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.18 indicates that MIT is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.18, MIT is doing good in the industry, outperforming 70.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 2.36
ROIC/WACC3.26
WACC5.96%
MIT.MI Yearly LT Debt VS Equity VS FCFMIT.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 2.89 indicates that MIT has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.89, MIT belongs to the top of the industry, outperforming 84.00% of the companies in the same industry.
  • MIT has a Quick Ratio of 1.90. This is a normal value and indicates that MIT is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.90, MIT is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.89
Quick Ratio 1.9
MIT.MI Yearly Current Assets VS Current LiabilitesMIT.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. MIT.MI Growth Analysis

3.1 Past

  • Measured over the past years, MIT shows a very strong growth in Earnings Per Share. The EPS has been growing by 106.03% on average per year.
  • Looking at the last year, MIT shows a decrease in Revenue. The Revenue has decreased by -2.49% in the last year.
  • MIT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.85% yearly.
EPS 1Y (TTM)N/A
EPS 3Y204.32%
EPS 5Y106.03%
EPS Q2Q%-91.85%
Revenue 1Y (TTM)-2.49%
Revenue growth 3Y-3.54%
Revenue growth 5Y5.85%
Sales Q2Q%25.86%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MIT.MI Yearly Revenue VS EstimatesMIT.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
MIT.MI Yearly EPS VS EstimatesMIT.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 -0.05 -0.1 -0.15

More info and screens

Find the best growth stocksShow best growing peers

4

4. MIT.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 2.81, which indicates a rather cheap valuation of MIT.
  • Based on the Price/Earnings ratio, MIT is valued cheaper than 92.00% of the companies in the same industry.
  • MIT is valuated cheaply when we compare the Price/Earnings ratio to 25.71, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 2.81
Fwd PE N/A
MIT.MI Price Earnings VS Forward Price EarningsMIT.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MIT is valued cheaper than 92.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.23
MIT.MI Per share dataMIT.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • MIT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.03
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

8

5. MIT.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 7.04%, MIT is a good candidate for dividend investing.
  • MIT's Dividend Yield is rather good when compared to the industry average which is at 2.38. MIT pays more dividend than 90.00% of the companies in the same industry.
  • MIT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 7.04%

5.2 History

  • The dividend of MIT is nicely growing with an annual growth rate of 31.64%!
Dividend Growth(5Y)31.64%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • MIT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
MIT.MI Yearly Income VS Free CF VS DividendMIT.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

More info and screens

Find the best dividend stocksShow peers with best dividend

MIT.MI Fundamentals: All Metrics, Ratios and Statistics

MITTEL SPA

BIT:MIT (3/5/2025, 10:29:18 AM)

1.745

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)N/A
Earnings (Next)04-22
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners79.04%
Ins Owner ChangeN/A
Market Cap141.96M
Revenue(TTM)151.39M
Net Income(TTM)50.50M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.04%
Yearly Dividend0.01
Dividend Growth(5Y)31.64%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.81
Fwd PE N/A
P/S 0.94
P/FCF N/A
P/OCF 16.71
P/B 0.56
P/tB 0.77
EV/EBITDA 1.23
EPS(TTM)0.62
EY35.53%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)0.1
OCFY5.98%
SpS1.86
BVpS3.11
TBVpS2.26
PEG (NY)N/A
PEG (5Y)0.03
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 12.51%
ROE 19.94%
ROCE 22.74%
ROIC 19.42%
ROICexc 25.34%
ROICexgc 34.77%
OM 49.36%
PM (TTM) 33.36%
GM 100.34%
FCFM N/A
ROA(3y)4.19%
ROA(5y)2.58%
ROE(3y)6.68%
ROE(5y)4.21%
ROIC(3y)14.88%
ROIC(5y)11.03%
ROICexc(3y)18.47%
ROICexc(5y)13.76%
ROICexgc(3y)25.01%
ROICexgc(5y)18.45%
ROCE(3y)17.14%
ROCE(5y)12.72%
ROICexgc growth 3Y36.07%
ROICexgc growth 5Y64.28%
ROICexc growth 3Y32.02%
ROICexc growth 5Y65.98%
OM growth 3Y8.63%
OM growth 5Y58.53%
PM growth 3Y215%
PM growth 5Y95.71%
GM growth 3Y0.76%
GM growth 5Y10.13%
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 0.54
Cap/Depr 198.12%
Cap/Sales 13.09%
Interest Coverage 28.12
Cash Conversion 10.03%
Profit Quality N/A
Current Ratio 2.89
Quick Ratio 1.9
Altman-Z 2.36
F-Score5
WACC5.96%
ROIC/WACC3.26
Cap/Depr(3y)179.03%
Cap/Depr(5y)134.19%
Cap/Sales(3y)13.45%
Cap/Sales(5y)10.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3Y204.32%
EPS 5Y106.03%
EPS Q2Q%-91.85%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.49%
Revenue growth 3Y-3.54%
Revenue growth 5Y5.85%
Sales Q2Q%25.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.29%
EBIT growth 3Y4.78%
EBIT growth 5Y67.8%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-514.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79.3%
OCF growth 3Y-29.55%
OCF growth 5Y-15.3%

MITTEL SPA / MIT.MI FAQ

What is the ChartMill fundamental rating of MITTEL SPA (MIT.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to MIT.MI.


What is the valuation status for MIT stock?

ChartMill assigns a valuation rating of 4 / 10 to MITTEL SPA (MIT.MI). This can be considered as Fairly Valued.


What is the profitability of MIT stock?

MITTEL SPA (MIT.MI) has a profitability rating of 9 / 10.


What are the PE and PB ratios of MITTEL SPA (MIT.MI) stock?

The Price/Earnings (PE) ratio for MITTEL SPA (MIT.MI) is 2.81 and the Price/Book (PB) ratio is 0.56.